Used in pharmaceutical research as a key intermediate in the development of central nervous system (CNS) active compounds. Shows potential in the synthesis of agents targeting neurological disorders due to its structural similarity to known neuroactive molecules. Its spirocyclic and heterocyclic framework enhances binding selectivity in receptor assays, particularly in studies related to serotonin and dopamine receptors. Also explored for use in cognitive enhancers and antidepressant drug candidates. Stable dihydrochloride salt form improves solubility and bioavailability in preclinical formulations.